Lisamarie Sarhangian
Oral and Maxillofacial Surgery · Chandler, AZNPI 1699061952
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,080 of the $6,739 with a category attached, or 60.5%. 8 manufacturers reported payments, led by Dentsply IH Inc. at 44.5% of the total. Reporting peaked in 2022 at $3,251 and has fallen 58.4% since, to $1,352 in 2025.
Across 29 payments — averaging $232.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dentsply IH Inc.$3K
- Dentsply LLC$1K
- Nobel Biocare USA$1K
- Straumann USA LLC$808
- Dentsply Sirona Inc$353
- Biohorizons Implant Systems Inc.$246
- plus $231 from 2 others
What the payments were for
- Speaking & faculty fees$4,08061%
- Travel & lodging$3776%
- Food & beverage$1,33720%
- Education$94514%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dentsply IH Inc. | 1 | $3,000 |
| Dentsply LLC | 1 | $1,080 |
| Nobel Biocare USA | 8 | $1,020 |
| Straumann USA LLC | 4 | $808 |
| Dentsply Sirona Inc | 5 | $353 |
| Biohorizons Implant Systems Inc. | 6 | $246 |
| Pacira Pharmaceuticals Incorporated | 3 | $135 |
| Zimvie Inc. | 1 | $97 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Implant Dentistry$4,080
- NOBELPARALLEL$795
- NOBELACTIVE$795
- BIOHORIZONS$603
- ATLANTIS$108
How this compares
$6,739 in reported general payments places this provider in the 85th percentile of 147 oral and maxillofacial surgery providers in Arizona.
See all oral and maxillofacial surgery providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 208 | $697 |
| Penicillin V Potassium | 187 | $591 |
| Ibuprofen | 115 | $349 |
| Chlorhexidine Gluconate | 79 | $308 |
| Clindamycin Hcl | 51 | $195 |
| Doxycycline Hyclate | 13 | $87 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $65 |
| Amoxicillin | 11 | $22 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Chandler
- Forrest PrattChandler$15K
- Kenny LamChandler$14K
- Leslie FishChandler$13K
- Jeffrey BobstChandler$7K
- Chase AndreasonChandler$5K
- Nishith ShahChandler$2K
- Brent BoyseMesa$201K
- Vishtasb BroumandScottsdale$92K
- Maureen PerryMesa$33K
- Sudheer SurpureFlagstaff$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.